1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Lupus or SLE: new trials by email Literature Review of Lupus or SLE trials Research Report on Lupus or SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Baricitenib to Maintain of Remission Baricitinib 4 MG, Baricitinib 2 MG, MMF - Lupus or SLE, Nephritis | Phase 2 / Phase 3 | Unknown | Assiut University | 80 | 2022-06-01 | 2023-01-17 |
Lupus Erythematosus, Systemic (1) · Nephritis (1)
Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Immune System Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Skin and Connective Tissue Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
baricitinib (1)
Egypt (1)